Type 2 Diabetes

Therapy shows neutral CV benefit, increases bleeding risk in type 2 diabetes.

Study finds treatment on top of stable renin angiotensin system (RAS)-inhibition decreased risk.

Diabetes increased modestly in general.

Male, 21 years of age has class III obesity, binge eating disorder, fatty liver, and asthma, and was recently diagnosed with type 2 diabetes. It is his freshman year at a college away from home. He eats in the cafeteria, and has no refrigerator or stove in his room. He visits today after not taking metformin or GLP-1 agonist since at starting school. He is under a lot of stress and states the food at school is terrible, unhealthy, and not diabetes-friendly at all. Note, he has been taught a lower carb meal plan. He says he is not taking Glucophage or Victoza; each of them at low doses gives him terrible diarrhea. He states he checks his glucose twice a week, with fastings in the 90-100 range. He is up 10 pounds since our last visit in September.

There has been a controversy over the last 30 years as to which is the best diet to prevent diabetes.

Cognitive decline in older adults with T2 may start to develop years before diagnosis, even in the prediabetes stages

Study also finds reduced heart rate variability (HRV) in overweight patients with newly diagnosed type 2 diabetes (T2D) and stable coronary artery disease (CAD).

New study finds adults with diabetes who have either high or low vitamin D levels could have an increased risk of cardiovascular autonomic neuropathy (CAN).

Using data from more than 1 million participants across four continents, researchers measured the precise benefits of exercise.

In this week's Homerun Slides, the conclusion of type 2 diabetes management strategies. Two case studies show the role of DPP-4 and SGLT-2/DPP-4 combo treatments.